Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000877195 | SCV001019895 | likely benign | Noonan syndrome 9 | 2024-11-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001731965 | SCV001983619 | benign | not specified | 2021-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372495 | SCV002667073 | likely benign | Cardiovascular phenotype | 2024-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000877195 | SCV002763118 | benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000877195 | SCV004562321 | likely benign | Noonan syndrome 9 | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004705857 | SCV005212007 | likely benign | not provided | criteria provided, single submitter | not provided |